Plasma Cytokine Profiles at Diagnosis in Pediatric Patients With Non-Hodgkin Lymphoma
Authors:
- Karin MellgrenKMKarin Mellgren
- Chris Juul HedegaardCHChris Juul Hedegaard
- Kjeld SchmiegelowKSKjeld Schmiegelow
- Klaus MüllerKlaus Müller
- 1 May 2012
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 34 (4) , 271-275
Abstract
Non-Hodgkin lymphoma (NHL) has been associated with elevated levels of inflammatory and immune-regulating cytokines, and polymorphisms in the genes encoding interleukin (IL)-10 and tumor necrosis factor (TNF)-α have been associated with increased incidence of certain subtypes of NHL. The aim of the present study was to screen for a broader spectrum of growth factors and inflammatory mediators and to compare the profiles in different subtypes of NHL in pediatric patients. Serum samples were collected at diagnosis from 31 pediatric patients diagnosed with NHL admitted at Rigshospitalet, Copenhagen, between 1995 and 2008. Cytokines and growth factors were measured in serum using the Luminex platform by application of a 30-plex kit. Levels of IL-6, IL-2R, IL-10, TNF-RI, and macrophage inflammatory protein-1α were significantly higher in patients with anaplastic large-cell lymphoma compared with patients diagnosed with B-cell lymphomas and lymphoblastic lymphomas. High levels of IL-4, IL-13, TNF-RI, and epidermal growth factor were associated with a poorer general condition at diagnosis. The present study suggests that NHL subgrouping and the general condition of pediatric patients at diagnosis are associated with plasma levels of growth factors and inflammatory mediators at presentation.Keywords
This publication has 27 references indexed in Scilit:
- MET signalling: principles and functions in development, organ regeneration and cancerNature Reviews Molecular Cell Biology, 2010
- Assessment of Pre-Diagnosis Biomarkers of Immune Activation and Inflammation: Insights on the Etiology of LymphomaJournal of Proteome Research, 2010
- Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective studyCancer Causes & Control, 2010
- Tumor Necrosis Factor (TNF) and Lymphotoxin- (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph ConsortiumAmerican Journal of Epidemiology, 2010
- A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphomaBlood, 2009
- Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL GroupJournal of Clinical Oncology, 2009
- Inflammatory cells and immune microenvironment in malignant lymphomaJournal of Internal Medicine, 2008
- Cancer-related inflammationNature, 2008
- Tumor Necrosis Factor and Lymphotoxin Alfa Genetic Polymorphisms and Outcome in Pediatric Patients With Non-Hodgkin’s Lymphoma: Results From Berlin-Frankfurt-Münster Trial NHL-BFM 95Journal of Clinical Oncology, 2005
- Hodgkin's Disease: A Cytokine-Producing Tumor − A ReviewCritical Reviews™ in Oncogenesis, 1994